1. Home >
  2. M&A >
  3. Special Situations/Distressed >
  4. United States >
  5. New York >
  6. New Mountain Capital Acquires Actylis

Special Situations/Distressed • Chemicals

New Mountain Capital Acquires Actylis

On April 16, 2019, private equity firm New Mountain Capital acquired chemicals company Actylis

Acquisition Context
  • This is New Mountain Capital’s 5th transaction in the Chemicals sector.
  • This is New Mountain Capital’s 53rd transaction in the United States.
  • This is New Mountain Capital’s 6th transaction in New York.

Explore All 7 Special Situations/Distressed Chemicals Deals - Search the Database Free


M&A Deal Summary
Date April 16, 2019
Target Actylis
Sector Chemicals
Buyer(s) New Mountain Capital
Deal Type Special Situations/Distressed

Target Company

Actylis

Port Washington, New York, United States
Actylis is a marketer, seller and distributor of products for human health (finished dosage form generics and nutraceutical products), pharmaceutical ingredients (pharmaceutical intermediates and active pharmaceutical ingredients), and performance chemicals (specialty chemicals and agricultural protection products). Actylis was formed in 1947 and is based in Port Washington, New York.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

New Mountain Capital

New York, New York, United States
Category Private Equity Firm
Founded 1999
PE ASSETS 55.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

New Mountain Capital is a private investment firm focused on investment in public and private companies in a variety of industries. New Mountain generally invests $100 to $500 million per transaction and looks for businesses with strong market positions and high barriers to entry. New Mountain also prefers businesses that succeed in both good and bad economies. Sectors of interest include education, healthcare, business services, federal IT services, media, software, consumer products, logistics, financial services and technologies, and energy. New Mountain Capital was formed in 1999 and is based in New York, New York.

Deal Context for Buyer #
Overall 57 of 104
Sector: Chemicals 5 of 6
Type: Special Situations/Distressed 1 of 2
State: New York 6 of 10
Country: United States 53 of 99
Year: 2019 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-12 Remedy Partners

Norwalk, Connecticut, United States

Remedy Partners is a technology, data, analytics, and services provider for the healthcare “bundled payments” sector, with offerings that both reduce healthcare costs and improve patient outcomes. Bundled payments link payments for the multiple services beneficiaries receive during an episode of care, enabling organizations to enter into payment arrangements that include financial and performance accountability for episodes of care. Remedy uses a proprietary database and advanced data and analytics to collaborate with health systems, at-risk providers, and employers in order to improve coordination of post-acute care.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-16 Avantor

Radnor, Pennsylvania, United States

Avantor is a provider of ultra-high purity materials and customized solutions to customers in the life sciences and advanced technology markets. Avantor was incorporated in 1904 and is based in Radnor, Pennsylvania.

Sell -

Explore Related M&A Activity

Chemicals M&A - Special Situations/Distressed M&A Deals - New York M&A - United States M&A - 2019 M&A

Mergr

Solution for

Product

Company

Legal